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The intestine is the shared site of nutrient digestion, microbiota colonization and immune 
cell location and this geographic proximity contributes to a large extent to their interac-
tion. The onset and development of a great many diseases, such as inflammatory bowel 
disease and metabolic syndrome, will be caused due to the imbalance of body immune. 
As competent assistants, the intestinal bacteria are also critical in disease prevention 
and control. Moreover, the gut commensal bacteria are essential for development and 
normal operation of immune system and the pathogens are also closely bound up with 
physiological disorders and diseases mediated by immune imbalance. Understanding 
how our diet and nutrient affect bacterial composition and dynamic function, and the 
innate and adaptive status of our immune system, represents not only a research need 
but also an opportunity or challenge to improve health. Herein, this review focuses on the 
recent discoveries about intestinal bacteria–immune crosstalk and nutritional regulation 
on their interplay, with an aim to provide novel insights that can aid in understanding their 
interactions.
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iNTRODUCTiON
Intestine plays an indispensable role in the origin of diseases as the 
shared principal junction of nutrients, microbiota, and immune 
response. There is a common view that commensal bacteria that 
count may more than 100 trillion in our gastrointestinal tract (1), 
influence the host health via influencing the operation of immune 
system, and they are essential for the development and normal 
operation of immune system. A delicate homeostasis between 
the commensal bacteria and the host immunity is also closely 
bounded up with physiological disorders and diseases mediated 
by the break of homeostasis, such as inflammatory bowel disease 
(IBD), metabolic syndrome, diabetes, allergy, and cancer (2). 
Modifying the bacterial community is becoming a potent way 
for diseases prevention and treatment. Furthermore, it is not to 
be ignored that bacterial species can produce costly and sufficient 
extracellular metabolites to benefit and affect host health only 
when a sufficient biomass of bacteria can benefit from the public 
goods of host, such as nutrients (3).
Hence, it is potential to modify immune response to attenuate 
and treat the aforementioned diseases via modulating gut bacte-
rial composition and functions. Nutrition intervention, probiot-
ics supplementation and bacterial transplantation are three 
alternative protocols to alter gut bacterial community nowadays, 
of which, nutrition intervention is a preferential choice in view 
of its high accessibility and security (4). Thus, to understand the 
cooperation and communication of bacteria and host immunity, 
nutrients should be the first factor need to be thought about.
Considering that the intestine is the shared site of nutrient 
digestion, microbe habitat, and immune cell location, this geo-
graphic proximity contributes to a large extent to their interac-
tion. It is necessary for us to focus on the recent discoveries about 
intestinal bacteria–immune crosstalk and nutritional regulation 
on their interplay with an aim to provide novel insight that can 
aid in understanding of their interaction.
THe CROSSTALK BeTweeN iNTeSTiNAL 
BACTeRiA AND MUCOSAL iMMUNe
The immune system consists of two parts: innate and adaptive 
immune system. They work cooperatively to defend the body 
against pathogen invasion and immune disorders. Generally, the 
immune response is produced throughout the whole body. The 
interaction and shared signal pathways exist between mucosal 
immune and intestinal bacteria. Immune signaling plays an 
essential role in managing the microbiota to maintain health 
homeostasis in the gut. Correspondingly, the mucosal immune 
also responses to the alteration of microbiota and the stimula-
tion of microbial metabolites. Here, we focus on the intestine 
to understand the bidirectional mediation of gut bacteria and 
intestinal innate and adaptive immune responses.
interaction between Gut Bacteria and 
innate immune System
Physical barriers, innate immune cells and molecules constitute 
the innate immune system, which is the first line to defend 
against pathogen infection. Within the intestine, these bacteria 
are controlled by the activity of neutrophils and macrophages via 
pattern recognition receptors (PRRs) to recognize and respond 
to abnormal changes of the microbial landscape. PRRs identify 
microorganism-associated molecular patterns (MAMP), mainly 
including peptidoglycan, flagellin, lipopolysaccharide (LPS), and 
nucleic acid structures of microbes (5). Some bacterial metabo-
lites from nutrient fermentation are also recognized by PRRs, 
such as butyrate.
So far, PRRs in the innate immune system sense microorgan-
isms through conserved molecular structures. PRRs consist of 
the toll-like receptors (TLRs), the nucleotide-binding oligomeri-
zation domain (NOD)-like receptors (NLRs), the retinoic acid 
inducible gene 1 (RIG-I)-like receptors (RLRs), the C-type lectin 
receptors (CLR), the absent in melanoma 2-like receptors and 
the 2’-5’oligoadenylates synthesis (OAS)-like receptors (OLRs) 
(6). Several cellular compartments contribute to the expression 
of these sensors, and they together constitute a continuous sur-
veillance system for the presence of microbes in gut. Here, we 
view PRRs as the indispensable components in innate immune 
system although some PRRs have been reported to participate in 
adaptive immune response simultaneously (7), and focus on two 
vital PRRs subfamilies, TLR and NLR, which are very prominent 
examples to understand bacteria–host interaction (Figure 1).
The Crosstalk between Intestinal Bacteria and 
Mucosal Barrier
The intestinal mucosa is a dynamic interface containing an epithe-
lial monolayer designed to separate the gut-associated lymphoid 
tissue from commensal bacteria community (8). Functionally, 
the intestinal mucosal barrier is the first natural line to defense 
against pathogen invasion via the cooperation of mucus layers, 
enterocytes, and tight junctions.
Pathogens and Mucosal Barrier
Gastric acid and protein hydrolase in the digestive tract destroy 
most of the pathogens that enter the intestine. However, some 
stubborn bacteria, such as Helicobacter pylori still exist, which 
survive in the acidic environment by changing the ambient pH. 
Thus, the effective close connection formed by epithelial cells 
ought to be a direct barrier to prevent the invasion of pathogens. 
However, some pathogens, such as many Enterobacteriaceae bac-
teria, can impair intestinal epithelial integrity and reduce mucus 
secretion, besides, Salmonella typhimurium can cause diarrhea, 
typhoid fever, and gastroenteritis.
The Absence and Existence of Commensal Bacteria Interact 
with Intestinal Immunity
Furthermore, the bidirectional function between mucosal barrier 
and intestinal pathogens also requires the interaction with com-
mensal bacteria, which not only contribute to defending against 
pathogens but also maintaining mucosal integrity and barrier 
function indispensably. The inner colon mucus layers capacity to 
separate bacteria from the epithelium is dependent on bacterial 
colonizers signaling to the host epithelium (9).
Several experiments carried out on germ-free (GF) 
mice were consistent with the necessity for the existence of 
FiGURe 1 | Effects of gut microbes on innate immune receptor. (A) Bifidobacterium infantis 35624 treatment increases IL-10 secretion through the TLR2/TLR6 
pathway in human myloid dendritic cell (mDC) and monocyte-derived DC (MDDC), while IL-10 secretion in plasmacytoid DC (pDC) is TLR9 dependent.  
(B) Lactobacillus acidophilus NCFM facilitates murine myeloid DC to express antiviral genes, such as myxovirus resistance 1, interferon (IFN)-β and interferon-
stimulated gene 56 (Isg56), via TLR2 pathway. (C) Lactobacillus delbrueckii subsp. delbrueckii TUA4408L (Ld) response against Enterotoxigenic Escherichia coli 
(ETEC) 987P infection in porcine intestinal epithelial cells. Acidic extracellular polysaccharide (APS) and neutral extracellular polysaccharide (NPS) of Ld attenuate 
inflammation dependent on TLR2 and TLR4, respectively. (D) Non-invasive Helicobacter pylori infection in NOD2−/− mice relies on NOD2 signaling to induce Th1 
inflammation response. (e) Non-invasive Clostridium difficile infection recruits neutrophils to infection sites via nucleotide-binding oligomerization domain protein 1 
(NOD1). (F) Citrobacter rodentium induces inflammation exacerbation in NLRC4−/− mice by producing IL17A and IFN-γ.
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commensal bacteria. It was reported that exposing to bacteria was 
a sufficient way for the intestine to stimulate mucus synthesis (10). 
Meanwhile, the maturity and abundance of mucus also depended 
on the intestinal bacteria. Similar researches found that in GF 
mice, small intestinal mucus was attached to the epithelium and 
the colonic inner mucus layer was penetrable to bacteria even 
though the mucus structure was similar to the conventional 
mice (9, 10). Besides, GF mice were also possessed a lower level 
of Muc2 O-glycans, which might be correlated with decreased 
glycosyltransferases responsible for O-glycan elongation (10). 
Interestingly, the reduction of Muc2 O-glycosylation could in 
turn hinder bacterial colonization, considering that glycan were 
utilized by bacteria as attachment sites and energy sources (10).
In addition, in the absence of symbiotic bacteria, the intestinal 
epithelial cells (IECs) and tight junctions tended to be impaired. 
The expression of tight junction proteins, the occludin and zonula 
occludens-1, was observed to reduce in GF mice (10). Compared 
to the conventional mice, enterocytes on the brush border 
were more irregularly arranged, and 30% of the enterocytes 
approximately were possessed of incomplete apical junctional 
complexes without desmosome in GF mice (11, 12). Fortunately, 
after colonizing Lactobacillus, the arrangement of microvilli was 
well organized and cytoskeletal microfilaments were anchored in 
the terminal web (13). The repair function and beneficial effect 
of probiotics on the intestinal barrier were also confirmed on 
Akkermansia muciniphila, a mucin-degrading bacterium com-
monly found in human gut. Their potential mechanisms might 
be associated with regulating the thickness of intestinal mucus in 
order to maintain the integrity of gut barrier.
TLRs Interact with Intestinal Bacteria
Pattern recognition receptors including the TLRs expressed by 
epithelial cells recognize MAMPs of the commensal bacteria 
and regulate the crosstalk between intestinal microbes and host 
(14, 15). Upon MAMP recognition, TLR form a homodimer or 
heterodimer to recruit the TLR-domain-containing adaptor pro-
tein, like myeloid differentiation primary response 88 (MYD88), 
TIRAP, TRIF, or TRAM, and then activate transcription factors, 
including nuclear factor kappa-light-chain-enhancer of activated 
B cells (NF-κB), activator protein 1, interferon-regulatory factor 
3 (IRF-3) and IRF-7 (14). The microbiota composition of the host 
is influenced by the status of TLRs and their adapter proteins 
(16, 17). Defects in TLR signaling and aberrant immune 
responses to perturbed endogenous microbiota are a few of the 
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major factors that contribute to the perpetuation of inflammation 
and tissue injury in patients with IBD (18, 19).
To date, 13 different TLRs have been identified. It has been 
reported that the expression of ileal TLR4, TLR5, and TLR9 
and colonic TLR3, TLR4, TLR6, TLR7, and TLR8 increased in 
antibiotic-treated mice, while ileal TLR2, TLR3, and TLR6 and 
colonic TLR2 and TLR9 decreased (17). And TLR2 and TLR4 
were upregulated in DSS colitic mice, while the expression of 
TLR5 decreased and other TLRs remained unchanged (20). The 
distinctive change of TLR pattern under unhealthy condition 
may indicate the differentiated functions of TLR members.
TLR2
TLR2 is expressed in enteric neurons and smooth muscle cells 
and senses various components from bacteria, mycoplasma, 
fungi, and viruses (18). Lactobacillus acidophilus NCFM facili-
tate murine myeloid dendritic cell (mDC) to express antiviral 
genes, such as myxovirus resistance 1, interferon-β (IFN-β), and 
interferon-stimulated gene 56, via TLR2 pathway (Figure  1B). 
Another study utilized Lactobacillus delbrueckii subsp. delbrueckii 
TUA4408L (Ld) as a mean to limit the response to Enterotoxigenic 
Escherichia coli 987P infection in porcine IECs (Figure 1C). And 
TLR2 was necessary for Ld to alleviate the inflammatory response. 
The presence of Bifidobacterium infantis 35624 increased IL-10 
secretion through the TLR2/TLR6 pathway in human mDC and 
monocyte-derived DC. A recent study also reported that the 
polysaccharide A of the fragile bacillus could activate TLR2 and 
promote the secretion of anti inflammatory cytokine IL-10 (21). 
Besides, TLR2 stimulation can also induce NF-κB activation in 
inflammatory disease and promote Th17 cell response to enhance 
the inflammation response (7, 22). So, TLR2 signal can induce 
both pro- and anti-inflammation responses. And the diverse 
immune responses depend on its co-receptor and microenviron-
ment (7).
TLR4
TLR4 is the first-identified and well-documented TLRs, which 
is vital in maintaining the fine balance between tolerogenic 
and inflammatory properties of gut microbiota by regulating 
innate immunity (23–25). It has been known that TLR4 signal 
induced by IFN-γ and tumor necrosis factor-α (TNF-α) could 
promote inflammation development (7). Increased epithelial 
TLR4 expression is observed in patients with IBD and associated 
with impaired epithelial barrier and altered epithelial cell dif-
ferentiation. Studies have confirmed the effective role of TLR4 in 
microbiota recognition, which recognized LPS on the cell surface 
with the help of CD14 and MD2 (26, 27) Furthermore, studies 
also showed that varied expression of TLR4 in different intestinal 
regions was determined largely by the bacterial composition of 
that region (23, 28).
In turn, epithelial TLR4 expression also shaped the intestinal 
microbiota. The overexpression of TLR4 is characterized by 
bacterial translocation and increased density of mucosa-
associated bacteria. More concretely, a decrease in Fusobacteria 
and Proteobacteria and an increase in Firmicutes in the colonic 
mucosa are found, which share the similarity with IBD patients 
(23, 29, 30). In addition, the increase of Lachnospiraceae and 
Gram-positive Coriobacteria is also significant. Meanwhile, the 
reduced number of Paneth cell could be observed, which play 
a role in limiting the penetration of commensal and invasion of 
pathogenic bacteria into the mucosa (23, 31). Several researchers 
also revealed that increased epithelial TLR4 signaling was associ-
ated with the altered expression of antimicrobial peptide (AMP) 
genes. The increased Reg3g and Lyz2 could not only modulate 
the composition of mucosal microbiota but also provide a first 
line to defense against mucosal association by bacteria (23, 32). 
Together, we imply that the bidirectional modulation between 
TLR4 and intestinal microbes does exist, and can ultimately alter 
the host susceptibility toward colitis.
TLR5
TLR5 is a transmembrane protein that is highly expressed in 
the gut mucosa and helps defend against infection (33). TLR5 
recognizes flagellin and is responsible for detecting the incursive 
bacteria and eliciting a series of proinflammation response by 
enhancing IgA production and Th1 and Th17 development (22). 
It is the other mean for the innate immune recognition, except for 
NLRC4 (34). TLR5 detects flagellin not only mediates bacterial 
locomotion (35) but also defends against flagellated pathogens. 
Unlike NLRC4, TLR5 can specifically help to manage the com-
mensal microbiota, and effectively eliminate patho-bionts which 
left can promote diseases (36, 37). As reported, the absence of 
TLR5 on IECs is sufficient to result in low-grade inflammation, 
metabolic syndrome, proneness to colitis, and dysregulated 
microbiota composition (33, 38). Specifically, the loss of the 
flagellin receptor TLR5 causes a small but not insignificant 
number of bacteria frequently breaching the mucus barrier to 
contact or surmount the epithelium, and also results in increased 
levels of flagellated bacteria (39, 40), which would likely have an 
increased ability to transit through the mucus layer and would, 
thus, likely be enriched in such perturbing bacteria. Moreover, in 
this process, higher level of LPS and fecal bioactive proinflamma-
tory flagellin are generated associated with altered microbiota.
Hence, these results above mean that there are exquisite 
MAMP recognition mechanisms on the TLR to ensure accurate 
response to bacteria. Meanwhile, the composition and activity of 
pathogens and commensal bacteria in gut are also regulated by 
TLR signaling. Above all, different TLRs cooperating with each 
other in MAMP recognition interact with intestinal bacteria in 
their relatively independent way.
NLRs Interact with Intestinal Bacteria
NLRs are located in the cytoplasm and have two subfamilies: 
nuclear oligomerization domain proteins subfamily C (NLRC) 
and nucleotide-binding oligomerization domain (NOD), leucine 
rich repeat and pyrin domain containing (NLRP) (31). Members 
of NLRC subfamily are nucleotide-binding oligomerization 
domain protein 1 (NOD1), NOD2, NLRC4, NLRX1, NLRC3, 
and NLRC5. The NLRP subfamily consists of 14 proteins with a 
pyrin domain.
NOD-like receptors are essential for recognizing bacteria to 
control the healthy gut microenvironment. Multiple studies have 
shown that mice lacking NOD1, NOD2, or NLPR6 exhibited 
alteration in their bacterial composition (24, 25, 30–32).
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NOD1 and NOD2
Among all the NLRs, NOD1 and NOD2 are the first-identified 
NLR members and play a vital role in pathogen recognition (31). 
Conversely, the altered composition and translocation of intesti-
nal bacteria will regulate the signaling of NOD1 and NOD2. In 
mucosal immune system, NOD1 and NOD2 combine with their 
ligands and then activate the receptor-interacting protein family 
2 and NF-κB pathway.
As reported, NOD1 recognizes the d-glutamyl-meso- 
diaminopimelic acid of Gram-negative bacteria and NOD2 
recognizes the muramyl dipeptide, which is the metabolite of 
peptidoglycan (41). Non-invasive Helicobacter pylori infection 
also relies on NOD2 signaling (Figure  1D) (32). Several stud-
ies showed that NOD1 was essential for defending against the 
non-invasive Clostridium difficile and Spi1-deficient Salmonella 
mutant infection (Figure 1E) (32, 33). In the absence of NOD2, the 
increased Bacteroides vulgatus was observed, which exacerbated 
the inflammation reaction, along with goblet cell dysfunction and 
abnormal expression of inflammatory genes (32).
Studies also confirmed the management of commensal bacte-
ria via NOD. However, some contradictions still existed. NOD1-
deficient mice exhibited abnormal expansion of the Bacteroides, 
Clostridiales, Enterobacteriaceae, and the segmented flamentous 
bacteria (SFB) (32), However, another study reported that 
there were no significant differences in the relative abundance 
of targeted bacterial groups between NOD1-deficient mice and 
wild-type littermates (42). Recently, the adjuvanticity of cholera 
toxin (CT) depended on recognition of commensal bacteria via 
NOD2 in CD11c+ cells and CT enhanced NOD2 activation via 
cAMP/PKA was also reported (43).
NLRC4
NLRC4, another member of NLRC subfamily, is reported to 
be expressed in epithelial crypts and plays an important role in 
intestinal health. Early NLRC4 sensing of Citrobacter rodentium is 
necessary for regulating its colonization and alleviating intestinal 
damage (Figure 1F) (34).
After being infected by Salmonella, NAIP belonging to IEC 
is combined with bacterioprotein ligands, such as flagellin (44), 
and then activates NLRC4 to form the inflammasome. Then the 
Caspase-1 or Caspase-8 in the downstream will be further acti-
vated. As reported, the activation of Caspase-1 leads to the death 
of IEC, the release of IL-8 and arachidic acid (45). In addition, 
Caspase-8 sensitized by downstream signal of NLRC4 also has 
the capacity to eliminate IEC (45). Paradoxically, in this process, 
the protective and pathogenic effects of Caspase-8 on Salmonella 
infection might both occur (44).
NLRP3
Nucleotide-binding oligomerization domain, leucine rich repeat 
and pyrin domain containing, such as NLRP3, NLRP6, and 
NLRP12 are the regulators of innate immunity (46). A recent 
study reported that NLRP6-deficient mice exhibited increased 
proportion of Bacteroidete and TM7 (40). As to NLRP12, patients 
with ulcerative colitis are associated with lower expression of 
NLRP12, which is the gene encoding the negative regulator of 
innate immune. The deficiency of NLRP12 in mice increases 
the basal inflammation of colon, reduces microbial density, 
eliminates protective strains of Lachnospiraceae, and promotes 
the prosperity of strains belonging to Erysipelotrichaceae and 
relating to colitis (47).
NLRP3 is an integral part of the inflammasome (48). Intestinal 
tract with hyperactive NLRP3 is more likely to maintain 
homeostasis and has a strong resistance to colitis and colorectal 
cancer (46). Based on our knowledge that increased expression of 
miR-223 was observed in intestinal inflammatory tissues of IBD, 
studies found that in the absence of miR-223, NLRP3 expression 
increased in colonic and medullary cells. Furthermore, miR-223 
in the inflammatory mononuclear cells could directly mediate 
NLRP3, in order to moderate the activity of the inflammatory 
corpuscle and inhibit colitis (48).
NLRP3 is also crucial in the interaction with intestinal 
microbiota. Hyperactive NLRP3 can enhance the secretion of 
IL-1β instead of IL-18 to promote the reconstitution of flora via 
increasing the local AMP. However, this function is only limited 
in mononuclear phagocytes of lamina propria. Microbial recon-
struction will further contribute to inducing Treg and managing 
to anti inflammation (46).
Due to the discovery of complex and opposing role of many 
PRRs in immune response, it is necessary to explore the under-
lying recognition mechanisms of most PPRs under different 
microenvironments and how they cooperate with each other 
to differentiate symbiosis from harmful bacteria to maintain 
the intestinal homeostasis. In summary, most PPRs deficiencies 
result in an abnormal makeup of the bacterial community. The 
healthy innate immune system contributes to the optimization 
of the gut bacterial composition and the dysbiosis of innate 
immune system may cause an imbalance within the gut bacteria 
community potentially leading to diseases.
interaction between Gut Bacteria and 
Adaptive immune System
In general, the adaptive immune system is initiated several days 
after pathogen infection and produces cytokines and specific 
antibodies cooperating with innate immune system to defend 
against subsequent pathogen invasion. The T  cells and B  cells 
are the two main immune cells involved in adaptive immune 
response. Memory T and B cells are further induced to respond 
to the secondary immune during the adaptive immune response.
In the intestine, the pathogens and commensal bacteria are 
both effective stimuli to induce the adaptive immune response. 
Conversely, the adaptive immune system is also a powerful 
weapon to resist pathogen invasion and regulates symbiotic flora. 
An aberrant and irrational state of gut bacteria community can 
be caused by the damage of the adaptive immune system. In the 
following section, we focus on the bidirectional effect on altered 
bacteria and adaptive immune response, including T cells dif-
ferentiation and secretory immunoglobulin A (SIgA) secretion.
Bacteria and T Cells Differentiation
Th1, Th2, Th17, Treg, and cytotoxic lymphocyte cells are the prin-
cipal effector T cells to regulate the adaptive immune response via 
FiGURe 2 | The effects of gut bacteria on T cells differentiation. (A) The polysaccharide A of segmented filamentous bacteria (SFB) induces Th17 cells differentiation 
and the antigen of SFB presented by dendritic cell (DC) is dependent on major histocompatibility complex II (MHCII). SFB adhesion induces Th17 accumulation by 
producing serum amyloid A (SAA) and reactive oxygen species (ROS). (B) The Bacteroides fragilis improves Treg cells differentiation mediated by PSA-activated DC. 
(C) Clostridia species induces Tregs accumulation presumably by cooperating with DC in the colon. (D) Butyrate, a large intestinal bacterial metabolite, drives 
colonic expansion of Treg cells in mice by reinforcing histone H3 acetylation in the promoter and conserving non-coding sequence regions of the Foxp3 locus.  
(e) Bacteria-producing Zwitterionic capsular polysaccharides (ZPS) can stimulate differentiation of Treg cells and IL-10 production dependent on antigen-presenting 
cell (APC). (F) Commensal A4 bacteria of Lachnospiraceae family inhibit Th2 cells production by increasing transforming growth factor-β (TGF-β) production of  
DC. (G) The Th17 cells produce IL-17, IL-21, and IL-22 to enhance inflammation response, while the Treg cells produce IL-10 to attenuate inflammation.
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cytokines production. The Th17 cells produce proinflammatory 
cytokines, such as IL-17, IL-21, and IL-22, to enhance inflamma-
tion. The Treg cells secrete the anti-inflammatory cytokine IL-10 
to attenuate inflammation. The dynamic balance between Th17 
and Treg cell differentiation is mediated by regulation of cytokine, 
such as IL-6, IL-21, and IL-2 (49, 50).
Within the intestine, some bacteria or certain known bacte-
rial mixes can affect the T cell generation and shape its subset. 
Recent studies showed that SFB primed and induced Th17 cells 
differentiation locally in the lamina propria. In addition, 
SFB adhesion to enterocytes induced Th17 accumulation by 
producing serum amyloid A and reactive oxygen species (51). 
Furthermore, the antigen of SFB presented by DC was depend-
ent on MHCII (52) (Figure 2). As to some commensal bacteria, a 
member of the Lachnospiraceae family, commensal A4 bacteria, 
was found to hinder Th2 cells development by inducing the 
transforming growth factor-β (TGF-β) production through its 
CBir1 antigen (Figure 2) (53). Several groups also have studied 
the effect of Clostridia colonization on T  cell differentiation 
and reported that the Clostridia could induce the expansion of 
Treg cells to suppress the inflammatory response of colitis mice 
(Figure 2) (54, 55). On the contrary, in GF mice, the colonized 
gut bacteria and LPS-rich sterile diet induced T and B  cell 
proliferation and differentiation in PP and MLN, especially the 
CD4+ Foxp3+T cells in MLN (56).
Furthermore, the products of bacteria, such as polysaccharide, 
could also affect T  cell differentiation. Polysaccharide A (PSA) 
from Bacteroides fragilis promoted Treg cell secretion and then 
suppressed Th17 activity to reinforce its intestinal coloniza-
tion (Figure  2) (57). A genomic screen for bacteria encoding 
for Zwitterionic capsular polysaccharides (ZPS), the bacterial 
product which can activate T cells function, was conducted. The 
lysates of ZPS-producing bacteria could stimulate differentiation 
of Treg cells and IL-10 production, which depended on antigen-
presenting cells (APC) (Figure 2) (58).
Moreover, the deficiency of T cell also exhibits altered bacteria 
(59). As reported, Disheveled 1 (Dvl-1) is an important protein of 
the Wnt/β-catenin pathway (60), which controls the proliferation 
of T cell progenitors and regulates T cell development and Treg 
cell activation (61–63). In Dvl-1 knockout mice, the gut bacterial 
composition is altered through the promotion of opportunistic 
pathogen growth, such as Helicobacter mastomyrinus, and hin-
derance of commensal bacteria growth (64).
Based on above researches, it can be speculated that regulation 
of T cell differentiation is a mechanism for gut commensal bac-
teria to support their own existence within the gut. Meanwhile, 
7
Ma et al. Nutrients, Bacteria, and Immune
Frontiers in Immunology | www.frontiersin.org January 2018 | Volume 9 | Article 5
the regular development and differentiation of T  cells are also 
efficiency in shaping microbiota and are required for maintaining 
intestinal microbial homeostasis.
Relationship between Bacteria and SIgA Secretion
SIgA is the most abundant antibody in the intestinal mucosa (65, 
66). It consists of IgA dimers and a polymeric immunoglobulin 
receptor-derived polypeptide termed secretory component which 
is secreted by enterocytes to stabilize the structure of SIgA and 
to anchor SIgA to mucus (67). Follicles of PP and MLN are the 
major suppliers of SIgA. In general, most SIgA are produced in 
T cell-dependent way (65, 68).
When stimulated by bacterial antigen, IgA+ B  cells in PP 
transfer to the intestinal stromal layer via lymphocyte homing 
to produce and secrete IgA into intestinal lumen. Then SIgA can 
aggregate potential and invasive pathogens to facilitate clearance 
of pathogens through intestinal peristalsis and mucosa cilia move-
ment. In addition, SIgA–pathogen complex can be engulfed by 
M cells and recognized by DC to enhance the immune response. 
The complex can also combine with T cells to induce IL-4, IL-10, 
and TGF-β production (69). However, the mechanism of how the 
SIgA distinguishes commensal bacteria from harmful bacteria is 
still unknown and more researches are needed to explore the 
underlying pathway.
As discussed before, the bidirectional function does exist 
between bacteria and T cells. Nevertheless, T cells may mainly act 
as the helper of B cells to promote the IgA production (59). Some 
studies also confirmed the relationship between bacteria and 
IgA. IgA could respond to SFB and E. coli MG1655 with different 
specificities and diversification profiles (70). Moor et al. proposed 
another pattern of IgA-pathogen complex formation, where IgA-
mediated cross-linking enchained daughter cells to form clumps 
eventually which could accelerate the clearance of pathogen from 
gut lumen and was efficient at all realistic pathogen densities (71).
Meanwhile, IgA is also a vital contributor to support the host–
bacteria homeostasis. In the absence of IgA, activation-induced 
cytidine deaminase-deficient mice (AID−/− mice) had more 
Firmicutes with increased SFB (72). It was also reported that a 
γ-Proteobacteria-specific IgA response was in part regulated by 
the transition from neonatal to mature bacteria (73). Presently, an 
in-depth study found that IgA-mediated intestinal homeostasis 
and altered bacterial composition were directed by MyD88 sign-
aling in gut T cells (74). Furthermore, confining the growth and 
inflammatory response of gut symbiotic flora and maintaining 
their diversity might be the two potential mechanisms of IgA 
regulating bacteria homeostasis (75).
ReGULATiON OF NUTRiTiON ON 
iNTeSTiNAL BACTeRiA AND MUCOSAL 
iMMUNiTY
Nutrients Supply to Bacteria and Modulate 
Their Composition
With the advancement of knowledge, very fascinating questions 
arise on host–microbe axis, particularly relating to nutrients that 
contribute to regulating bacteria composition and maintaining 
the homeostasis of intestinal microenvironment. A wealth of 
researches suggest that different diets provide the energy needs 
for bacteria proliferation and foster the distribution of distinct 
microbial communities. Besides, given many studies, deficiency 
and imbalance of macronutrients, mainly carbohydrate, fat, and 
protein, can lead causes of metabolic diseases, inducing obesity 
and insulin resistance (76), and can also adversely impact the 
intestinal bacteria. It is not to be ignored that nutrition interven-
tion is also the alternative protocol to ameliorate immune imbal-
ance by altering gut bacterial community nowadays.
Carbohydrate
Generally, the primary nutrient source for the gut bacteria is non-
digestible dietary carbohydrates (NDC), which includes resistant 
starch (RS), non-starch polysaccharides (NSP), oligosaccharides, 
and unabsorbed sugars and sugar alcohols (1). Among NDC, RS 
and NSP are major bacterial carbon nutrients. Of course, sloughed 
epithelial cells and secreted mucus from intestine are also the vital 
fuel for energy supply for bacteria (1). The fermentation of NDC by 
bacteria leads to the production of short-chain fatty acid (SCFA), 
mainly acetate, propionate and butyrate. Meanwhile, by the inter-
vention of NDC, the composition of saccharide-degrading bacteria 
is also altered. As reported, high-RS diets could induce popula-
tions of Ruminococci and inulin-derived prebiotics might increase 
the proportion of Bifidobacteria and Faecalibacterium prausnitzii 
(77). Meanwhile, reduced availability of NDC lowered bacterial 
diversity and the concentration of fiber-degrading bacteria, such 
as Bacteroides ovatus, Eubacterium rectale, and increased mucin-
degrading bacteria (78). However, the inconsistent outcomes about 
the effects of NDC on intestinal microbial composition also have 
been observed according to several studies (79, 80). We suggest 
that the discrepant response of intestinal bacteria to NDC depriva-
tion may depend on the complexity of bacteria composition and 
differences in pre-experiment individual bacteria.
A postulation in a report suggested that high diversity-fiber 
diets could induce high bacteria diversity (81). In addition, Chen 
et al. conducted a study to explore the fermentability of two fibers 
with different chemical structures by two fiber-utilizing bacteria, 
Prevotella and Bacteroides, and found that Prevotella-dominated 
bacteria instead of Bacteroides-dominated bacteria, could degrade 
quantitatively more fiber and produce more SCFA, especially pro-
pionate. After fermenting fiber substrates by fecal bacteria in vitro, 
the proportion of Prevotella was increased. In addition, the altera-
tion in the Bacteroides-dominated enterotype group was dependent 
on fiber structure to a great extent, which suggested that Bacteroides 
possess higher substrate specificity than Prevotella (82).
However, in the large intestine, there are discrepancies 
on nutrient utilization among different bacteria. Bacteroides, 
Prevotella, Clostridium cluster XIV and IV are considered the 
carbohydrate-utilizing bacteria, in addition, the Bacteroides 
genus can also degrade mucus (1).
Dietary Fat
Dietary fat has been suggested to be the major contributing 
factor for gut bacteria modification rather than protein/sucrose 
ratio (83). Many studies reported that high-fat diet increased 
the proportion of Firmicutes and lowered the proportion of 
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Bacteroidetes, especially S24-7 and Bacteroides (84–86). This 
conclusion was also supported by other researches where similar 
outcomes were reported: greater Enterobacteriaceae populations 
in pigs fed a high-fat diet and greater Lactobacilli, Bifidobacteria, 
and Faecalibacterium prausnitzii in pigs fed a low-fat diet (87).
Protein
As to protein, excessive intake of protein always lead to higher 
colonic input (88). The degradation of excess proteins in colon 
start with hydrolysis of proteins into smaller peptides and amino 
acids (AA) by bacterial proteases and peptidases that are more 
active at neutral to alkaline pH. These residual proteins not only 
elevate intestinal pH but are also potentially available to the 
colonic microbes for further metabolism (89). The community 
of proteolytic bacteria is mainly altered. It has been reported that 
the primary bacteria related to protein metabolism in the small 
intestine consist of Klebsiella spp., E. coli, Streptococcus spp., 
Succinivibrio dextrinosolvens, Mitsuokella spp., and Anaerovibrio 
lipolytica (90). However, in the large intestine, the proteolytic 
activity of monogastric animals has been mainly attributed to 
the genera of Bacteroides, Propionibacterium, Streptococcus, 
Fusobacterium, Clostridium, and Lactobacillu (91). These domi-
nant bacteria are not only capable to secrete various proteases and 
peptidases to degrade proteins, some of them could also directly 
metabolize AA. Furthermore, Prevotella ruminicola, Butyrivibrio 
fibrisolvens, Mitsuokella multiacidas, and Streptococcus bovis could 
secrete highly active dipeptidyl peptidase for protein digestion 
and absorption in the monogastric animals which community 
increased in the intervention of high protein level. With the 
participation of these proteolytic bacteria, branched-chain amino 
acids (BCAA), biogenic amines, and other metabolites (1, 92) 
from aromatic AA, such as phenylacetic acid, phenols, and indoles 
(93), could be derived in the process of protein fermentation.
Unlike single nutrient excesses or insufficiencies described 
above, malnutrition is an unsound state characterized by long-
term inadequate or excessive nutrition. In fact, undernutrition 
is the main factor of death in children under 5  years old (94), 
while overnutrition is one of the chief culprits leading to obesity, 
diabetes, and metabolic syndrome and both have been associated 
with alterations in bacterial populations. Enterobacteriaceae, 
Neisseriaceae (Proteobacteria) and Streptococcaceae (Firmi-
cutes) are enriched in association with undernutrition. Bifido-
bacteriaceae, Coriobacteriaceae (Actinobacteria), Prevotellaceae  
and Bacteroidaceae (Bacteroidetes), Clostridiaceae, Eubacteriaceae, 
Lachnospiraceae, Lactobacillaceae, Ruminococcaceae, and 
Veillonellaceae (Firmicutes) are reported to be depleted in 
innutrition (94, 95). Most are dominant bacteria in healthy gut. 
Hence, malnutrition will result in radical change of bacteria that 
is adverse to nutrition utilization and intestinal homeostasis to 
defend pathogens infection.
Nutrients at the interface of Host 
immunity
Functional Amino Acids
Increasing evidences confirm that the intestinal immune and 
barrier functions are modulated by nutrients, while functional 
AA are prominent factors among them (Figure 3).
BCAA are EAA in mammals, which play vital roles in 
innate immunity as an indispensable nutrient maintaining the 
function of immune system. The absence of BCAA, especially 
isoleucine (Ile), impairs the innate immune function in cells 
or organisms (96), which is due to the shortage of lympho-
cytes and white blood cells. Concerning the gut, BCAA can 
also stimulate mucosal immunity and maintain intestinal 
integrity. Studies illustrate that the addition of BCAA limits 
intra-epithelial lymphocytes and decreases immunoglobulin 
concentration in the small intestine. BCAA stimulates intes-
tinal SIgA secretion, which is a main immunoglobulin to 
improve the mucosal surface defense (97). The high amount 
of SlgA in the intestinal lumen is expected to be a better 
protection to inhibit pathogen introgression into the lamina 
propria (98).
Tryptophan is one of the EAA which cannot be synthesized 
independently by humans and animals, thus, need to ingest from 
food. Nowadays, several researches suggest that tryptophan 
seems to become a promising new target to modulate immune 
responses. Trytophan absorbed by IECs directly activates the 
mTOR pathway by intracellular tryptophan receptors through 
a PI3K/AKT-independent mechanism (99, 100). As we known, 
mTOR plays an important role in connecting metabolism and 
immunity. Active mTOR functions on promoting cellular pro-
cesses and regulates AMPs expression (96) while suppressed 
mTOR reduces nutrition biosynthesis and increases autophagy 
(101). Increasingly large numbers of studies also show the 
beneficial effects of tryptophan on IBD development, which may 
serve as a potential candidate for treating IBD due to its benefit 
on intestinal barrier.
Polysaccharide
Many bioactive polysaccharides from various sources have been 
characterized, which are macromolecular carbohydrates com-
prised of monosaccharides serving as the most important com-
ponents of organisms. As reported, polysaccharides are widely 
involved in antitumor, antidiabetic, antioxidant, antiviral, and 
immunomodulatory activities. They are also efficient of multiple 
physiological activities, such as cell differentiation, proliferation, 
and signal transduction (102–104) (Figure 3).
Fructo-oligosaccharide and inulin are considered as prebiot-
ics, which consumption can induce immune-modulatory effects. 
However, this modulatory function is traditionally thought to 
reflect microbial interactions within the gut, which is contradic-
tory with the recent evidence that non-digestible oligosaccharides 
directly regulate host in microbe-independent mechanism. In 
the process of directly regulating host mucosal signaling, IECs 
are hyporesponsive to activate NF-κB and mitogen-activated 
protein kinase (MAPK) induced by pathogens, when exposed to 
oligosaccharides. A differential kinome profile is observed when 
compared to those cells belonging to multiple innate immune 
signaling pathways. In addition, administrating non-digestible 
oligosaccharides orally can attenuate inflammatory response 
to LPS without changing intestinal microbiota. Thus, oligosac-
charides can act as a kind of potent candidates to regulate host 
inflammation via directly modulating kinome instead of altering 
gut microbiota (105).
FiGURe 3 | The effect of nutrients at the interface of host immunity. (A) The absence of branched-chain amino acids (BCAA) impairs the innate immune function 
due to the shortage of lymphocytes and white blood cells. BCAA can also stimulate the secretion of SIgA to improve the mucosal surface defense and inhibit 
pathogen introgression into the lamina propria. (B) Trytophan (Trp) is absorbed by intestinal epithelial cells (IECs) directly activates the mTOR pathway by intracellular 
Trp receptors through a PI3K/AKT independent mechanism. The active mTOR connects metabolism and immunity, promoting cellular processes, and regulating 
AMPs expression. (C) Fructo-oligosaccharide and inulin are considered as prebiotics, affecting IECs to be hyporesponsive to activate nuclear factor kappa-light-
chain-enhancer of activated B cells (NF-κB) and mitogen-activated protein kinase (MAPK) induced by pathogens. Inflammatory response to lipopolysaccharide (LPS) 
would also be attenuated in this process. (D) G. lucidum polysaccharides (GLP) can effectively ameliorate the sensitivity of insulin, reducing low-grade chronic 
inflammation and inhibiting the outflux of plasma triglyceride and non-esterified fatty acid by suppressing the expression of tumor necrosis factor-a (TNF-α), 
interleukin-6 (IL-6), and hormone-sensitive lipase. (e) After ginseng polysaccharides (GS-P) treatment, the secretion of tumor necrosis factor-α (TNF-α) and 
interleukin-12 (IL-12) are increased and the macrophage and NK cell are activated. They both suppress the tumor metastasis.
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G. lucidum polysaccharides (GLP) can effectively ameliorate 
the sensitivity of insulin. After GLP treatment, insulin concentra-
tion in plasma is decreased and the systemic insulin resistance 
can be reversed. In this process, GLP is also potent in dampening 
low-grade chronic inflammation and inhibiting the outflux of 
plasma triglyceride and non-esterified fatty acid by suppressing 
the expression of TNF-α, interleukin-6 (IL-6), and hormone-
sensitive lipase. Therefore, by regulating inflammatory cytokines, 
GLP is efficient to improve insulin sensitivity.
Researchers discovered a kind of polysaccharides from gin-
seng leaves (GS-P) in China recently. More importantly, tumor 
metastasis can be suppressed after GS-P treatment via activating 
macrophage and NK cell. Meanwhile, the secretion of TNF-α and 
IL-12 is also increased in peritoneal exudate macrophages (106).
In addition, β-glucans are kinds of natural polysaccharides 
and biologically active fibers with proven medical significance as 
potential probiotics. Being confirmed in vitro, as well as animal- 
and human-based clinical studies, taking β-glucans orally is of vital 
effect on antitumor, anti-inflammatory, anti-obesity, anti-allergic, 
anti-osteoporotic, and immunomodulating activities (107).
Moreover, the multi-omics approach is applied to investigate 
impacts of longan polysaccharide on host immune system. Results 
show that the level of IgA, IgG, IgM, IL-6, IFN-γ, and TGF-β is 
increased, which means an improvement of immunomodulatory 
activity.
NUTRieNTS MeDiATe THe BACTeRiA–
iMMUNe CROSSTALK THROUGH 
MiCROBiOMe-MODULATeD 
MeTABOLiTeS
A large repertoire of metabolites of bacteria harbor in the 
mammalian intestine and associated mucosal immune system. 
They are usually small molecules with biological activity which 
are mainly produced from nutrition-related sources or endog-
enously (108).
Nutritional composition tremendously impacts the genera-
tion and scale of bacterial metabolites (108). With studies focus-
ing on diverse substrates, it appears that protein breakdown and 
FiGURe 4 | Tryptophan mediates the bacteria–immune crosstalk. When induced by proinflammatory cytokines, the majority of tryptophan is metabolized through 
the kynurenine (Kyn) pathway mediated by indoleamine 2,3-dioxygenase (IDO). Kyn can serve as agonists for aryl hydrocarbon receptor (AhR), and act on dendritic 
cell (DCs) to inhibit DCs maturation. Through AhR, Kyn can cause T cell energy loss and apoptosis, promote the proliferation of Treg and Th17 cells, and also 
decrease the differentiation of highly inflammatory Th17 cells and enhance the generation of IL-22 and IL-10. Tryptophan can be degraded to 5-HT by the aid of 
Tryptophan hydroxylase gene (TPH1). Corynebacterium spp., Streptococcus spp., and Escherichia coli can also synthesize 5-HT themselves from tryptophan. 
Spore-forming bacteria (Sp) can regulate the concentration and synthesis of 5-HT. Melatonin can be then secreted after 5-HT, which can affect the differentiation of 
Th17 cells in the intestine.
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fermentation by microbes produce ammonia, amines, phenols, 
and branch chain fatty acids. In addition, multiple functional 
amino acids are also generated in this process and involved in 
immune response, such as tryptophan. SCFA are mainly derived 
in the metabolism of carbohydrate and fiber rich diet, and then 
play an important role in regulating a variety of physiological 
activities (109).
This variety of local metabolites affect on mucosal and systemic 
immune maturation and are involved in multiple immune signal-
ing pathways with the participation of macrophages, dendritic 
cells (DCs), T cells, and innate lymphoid cells (ILCs) (110, 111). 
Moreover, many systemically absorbed metabolites may reach 
remote organs and modulate immune responses in sterile host 
regions (112, 113). The type, composition, concentration, and 
even the misbalance of metabolites coupled with the host sensor 
molecules orchestrate the immune function, no matter in steady 
state or during disease (114, 115).
On the basis of the intimate crosstalk existing between intesti-
nal mucosal immune system and microbiota, metabolites gener-
ated from dietary nutrients may serve as an important bridge 
to connect the communication and regulation among nutrient, 
immune and bacteria. Furthermore, this complex network may 
be driven by metabolite secretion and signaling (108).
Tryptophan Mediate immune Response 
through Metabolites
Tryptophan is essential for human activity and animal produc-
tion. Besides the part of tryptophan that is utilized to synthesize 
protein, the other portion is catabolized to produce variety 
bioactive compounds, such as kynurenine, serotonin, melatonin, 
and so on, to regulate physiology functions and correspond to 
immunal response (Figure 4).
Kynurenine
When induced by proinflammatory cytokines, the majority of 
tryptophan is metabolized through the kynurenine (Kyn) path-
way mediated by indoleamine 2,3-dioxygenase (IDO) in mam-
mal intestine. Meanwhile a range of active metabolites known 
as Kyn are generated involving in immune response. Kyn itself 
is a compound which is almost devoid of biological activity as 
regarded, but can serve as the ligand for aryl hydrocarbon recep-
tor (AhR) (116).
Aryl hydrocarbon receptor was originally identified as a 
dioxin detoxifying enzyme, a cytoplasmic transcription factor 
that was activated by many kinds of compounds (117). Kyn can 
serve as agonists for AhR receptor (118), and act on DCs and 
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inhibit DCs maturation, which further control immune surveil-
lance via major APC (119). Moreover, through AHR, KYN can 
cause T cell energy loss and apoptosis and also promote the pro-
liferation of Treg and Th17 cells, as well as alter the response of 
Th1/Th2. Studies also found that coculturing with DCs and naïve 
T cells in the absence of AhR suppressed the later differentiation 
of Treg cells. However, adding Kyn into this system can redeem 
this effect to a certain extent and also decrease the differentiation 
of highly inflammatory Th17 cells and enhance the generation of 
IL-22 and IL-17 (120, 121). When focus on the intestinal immune 
system, the enhancement of IL-22 by ILC3 (122) and IL-10 
receptor protein in IECs (123) is observed in the involvement of 
Kyn-derived AhR ligands. It has been demonstrated that IL-10 
signaling in the epithelium is vital in promoting cell prolifera-
tion and forming barrier (124, 125). The deficiency of AhR or 
its receptor may cause spontaneous colitis (126) and destroy the 
intestinal homeostasis.
5-Hydroxytryptamine [Serotonin (5-HT)]
Besides its character as an important neurotransmitter, the 5-HT 
is also a potent secretagogue and a significant regulatory factor 
in digestive tract with manifold biologic functions, including the 
mediation of intestinal secretion and motility (127–129). The 
majority of 5-HT is released from EC cells, which is not only able 
to adjust diversified physiological function in GI (127) but also 
expands its function in modulating immune and communicating 
to mucosal immune cells closely (127, 130). Immune cells of innate 
and adaptive system are associated with various 5-HT receptors 
(131), including lymphocytes, monocytes, macrophages, T cells, 
B cells, and dendritic cells (132).
The level of serum 5-HT can be affected by gut microbes, which 
was emphasized recently. In GF mice, concentrations of 5-HT are 
substantially reduced comparing to the conventionally colonized 
control group (128, 133). Indigenous spore-forming bacteria from 
the healthy individual enhance the level of 5-HT due to promot-
ing its biosynthesis in colonic EC cells and then release 5-HT to 
mucosa and lumen (134). In addition, metabolites derived from 
Sp are also capable for colonic ECs to promote 5-HT biosynthesis 
(128). Thus, it can be demonstrated the direct regulatory effect 
of Sp on the concentration and synthesis of 5-HT. In addition, 
some specific bacterial strains, such as B. fragilis, B. uniformis, 
SFB, and altered Schaedler flora (ASF), can effectively alter the 
level of 5-HT in both colon and serum. Corynebacterium spp., 
Streptococcus spp., and E. coli, can synthesize 5-HT themselves 
from tryptophan in vivo (135).
Furthermore, the alteration of 5-HT mediated by microbiota 
regulates intestinal microenvironment. Specifically, the distur-
bance of enteric flora can cause the imbalance of 5-HT levels while 
the exertion of probiotics can significantly alleviate the symptoms 
of 5-HT dysbiosis (133). Thus, targeting bacteria may be serve as 
a prefer method to regulate peripheral 5-HT bioavailability and 
treat disease symptoms (128).
Role of Melatonin and Other Metabolites
Melatonin can be synthesized from tryptophan, which is pro-
duced from the pineal gland and the enterochromaffin cells of 
the intestine mucosa (136). As reported, melatonin can act as a 
potential candidate to treat IBD for its immunomodulatory func-
tion. Specifically, after melatonin treating, the differentiation of 
TH17 cells is observed to be regulated in the intestine (137). The 
intestinal commensal bacteria can also catabolize tryptophan to 
indole, indole 3-propionic acid (IPA) or indole-3-aldehyde (I3A). 
Recently, a study revealed that except Clostridium sporogenes, 
there were other four bacteria, Peptostreptococcus anaerobius 
CC14N and three strains of Clostridium cadaveris utilizing 
tryptophan to produce IPA, because all these bacteria encode 
the phenyllactate dehydratase. The study successfully modified 
the metabolic output by bacterial genetic engineering to regulate 
the intestinal homeostasis at the first time. In the context of the 
study, the metabolic pathways of tryptophan in Clostridium 
sporogenes were demonstrated and the generated IPA was verified 
to decrease the intestinal permeability. The result was consistent 
with a previous study, which suggested that IPA could promote 
the intestinal barrier function via PXR and TLR4 pathway (138). 
Apart from IPA, tryptophan can be catabolized by lactobacilli to 
I3A to prevent the colonization of Candida albicans and protect 
against mucosal inflammation through AhR recognition.
Carbohydrates Mediate immune 
Response through SCFA
SCFAs, including acetate, propionate, and butyrate, can provide 
energy for colonic epithelial cells and decrease luminal pH to inhibit 
the growth of pathogens (139). Except for aforementioned funda-
mental function, SCFAs can regulate the intestinal immunity in 
different ways. First, SCFAs can affect the intestinal distribution 
of immune cells. It is reported that butyrate negatively regulates the 
number of three ILCs in terminal ileal PPs, then results in the 
increment of Treg cell (140).
Second, innate and adaptive immunity can also be tuned. 
Because there are so many reviews that have summarized the 
function of SCFAs on body immune up to now (141–143), we 
collect the SCFA-related reports in last 2 years to present their lat-
est progresses. Butyrate is reported to improve the expression of 
TLR5 to enhance the flagellin-induced immune responses through 
regulating the binding of Sp to TLR5 promoter (144). Propionate 
and butyrate can inhibit the CD8+ T cell activation to tolerate 
the immunity stimulation through dampering the secretion of 
IL-12 from DC (145). A recent study also showed that the acetate 
induced B cells to produce IgA via the retinoic acid pathway and 
the SCFA receptor GPR43 in vitro and in vivo (146). Similar to 
this study, mixed SCFAs (acetate, 70 mM; propionate, 30 mM; 
butyrate, 20 mM) could improve the IgA and IgG responses by 
regulating the gene expression for antibody production in B cells 
(147). However, in contrary to the results which demonstrated 
that butyrate mainly enhanced the acetylation of Foxp3 (148), 
a recent report suggested that the effect of butyrate on immune 
system depended on its concentration and its microenvironment. 
They found that lower butyrate could improve the Treg cell differ-
entiation with the help of TNF-β while higher butyrate induced 
the expression of Th1-associated factor T-bet and IFN-γ, which 
was detrimental for intestinal mucosa homeostasis (149). At the 
same time, butyrate is found to increase the LL37 (an AMP) resist-
ance of enterohemorrhagic Escherichia coli (EHEC) by enhancing 
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the expression of ompT in EHEC and then producing more outer 
membrane vesicles. This phenomenon may be explained to the 
adaptation of EHEC to luminal environment for maintaining 
its survival. Hence, the role of SCFAs in intestinal homeostasis 
varies with their concentration and luminal microenvironment. 
In addition, SCFAs can protect against food allergy cooperating 
with vitamin A, which indicate the synergistic function of SCFAs 
and vitamin A on immunology regulation (150).
Generally, increment of luminal SCFAs relies on dietary fiber 
supplementation, and high-fiber diet produces more SCFAs. But 
it is unknown how much fiber is converted to SCFA. A study 
performed a stable isotope study to determine the systemic avail-
ability of SCFA by administrating 13C-labeled SCFAs into colon 
with colon delivery capsules. And they found 36% acetate, 9% 
propionate, and 2% butyrate from colon entered into circulation. 
This research is conducive to quantify SCFA production from 
13C-labeled fibers by determining the systemic SCFA concentra-
tion in the future to determine the availability of colonic bacteria 
on fiber and then to achieve the accurate supplementation of 
dietary fiber in disease treatment.
CONCLUSiON
The available research demonstrates the interplay of bacteria–
immune and nutrient-regulatory role in intestine. Additional in-
depth studies are needed to uncover the underlying mechanisms 
of these interactions. The identification of specific nutrients 
involved in bacteria regulation and specific commensal bacteria 
involved in immunological regulation may allow the development 
of novel nutrient regulators used in clinical medicine as a method 
for the treatment of nutrient-bacteria-immune-related diseases.
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